Resistive Expiratory Muscle Training in COPD Patients

Not Applicable

Completed

• Conditions: COPD
• Interventions: Other: Resistive Expiratory muscle Training Group; Other: Conventional Breathing Exercise Group

• Registration Number: NCT05061186
• Lead Sponsor: Riphah International University

Brief Summary

* To determine effects of resistive expiratory muscle training on pulmonary functions in Chronic obstructive pulmonary disease (COPD) patients

* To determine effects of resistive expiratory muscle training on maximum expiratory pressure in COPD patients

* To determine effects of resistive expiratory muscle training on quality of life in COPD patients

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2021-09-18
• Study First Submitted QC: 2021-09-18
• Study First Posted: 2021-09-29
• Study Start: 2021-10-10
• Primary Completion: 2022-01-15
• Study Completion: 2022-01-15
• Status Verified: 2022-02
• Last Update Submitted: 2022-02-01
• Last Update Posted: 2022-02-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 74

Inclusion Criteria

• COPD patients (GOLD criteria - moderate, moderately severe)
• Borg scale < 4

Read More

Exclusion Criteria

• Patients with Orthopedic disease
• Neurological disease,
• Cognitive impairment (Mini-Mental State Examination < 22) ,
• Heart diseases,
• Pulmonary fibrosis
• Obstructive sleep apnea syndrome.
• Acute and chronic infections

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Resistive Expiratory muscle Training Group	Resistive Expiratory muscle Training Group	Mild Resistive Expiratory muscle Training Group
Conventional Breathing Exercise Group	Conventional Breathing Exercise Group	Breathing Ex: Pursed lip Breathing, Diaphragmatic breathing ex, incentive spirometer

Primary Outcome Measures

Name	Time	Method
Maximum expiratory pressure	6 weeks	Maximum expiratory pressure (MEP) measures the maximum positive pressure that can be generated from one expiratory effort starting from total lung capacity (TLC) . Changes will be assessed from the baseline and at the end of the intervention after 6 weeks
St George's Respiratory Questionnaire	6 Week	This is a specific respiratory instrument developed for patients with COPD. Its validity, reproducibility and response to change over time have been demonstrated. It has three components: symptoms, activity and impact. The responses to the items can be aggregated into an overall score and three sub-scores for symptoms, activity and impact in the range 0-100%. Higher scores indicate a poorer quality of life).Changes will be assessed from the baseline and at the end of the intervention after 6 weeks
Forced Expiratory Volume in 1 second (FEV1)	6 Week	Changes from the Baseline, the digital spirometer is used in clinical setting to analyze Forced Expiratory Volume in 1 second FEV1 in Liters
Forced vital Capacity (FVC)	6 week	Changes From the Baseline, the digital spirometer is used in clinical setting to analyze Forced vital Capacity in Liters.
Peak Expiratory Flow (PEF)	6 Week	Changes from the Baseline, the digital spirometer is used in clinical setting to analyze peak expiratory flow PEF in Liter/second.
Volume of Lungs inflation	6 week	The incentive spirometer is a device that encourages patients with visual and other positive feedback, to maximally inflate their lungs and sustain that inflation. It is a common mode of postoperative respiratory therapy and involves deep breathing facilitated by a simple mechanical device. Maximal volume of lung inflation is thought to open collapsed alveoli and thereby prevent and resolve atelectasis. When all three balls reached their column tops, it indicated that the subject was able to generate inspiratory airflow of 1200 ml/ml. When only two balls reached their column tops, it indicated that the subject generated 900 ml/min. When only one ball reached their column tops, it indicated that the subject could only generate 600 ml/min. Changes will be assessed from the baseline and at the end of the intervention after 6 weeks

Trial Locations

Locations (1)

Holy Family Hospital; 🇵🇰 Rawalpindi, Punjab, Pakistan